VitaPath Genetics, a molecular diagnostics company, closed a $6m series A round of funding led by MDV-Mohr Davidow Ventures.
Foster City-Ca.-based VitaPath was originally seeded by X/Seed Capital, which also co-invested in this round.
The funds will be used to complete the validation of the company’s first assay and prepare for commercial launch.
FinSMEs
10/09/2009